World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 30 October 2017
Main ID:  ISRCTN05282752
Date of registration: 30/11/2005
Prospective Registration: No
Primary sponsor: Pfizer Inc. (USA)
Public title: Effect of valdecoxib pretreatment on pain and secondary hyperalgesia associated with the heat/capsaicin model in healthy volunteers
Scientific title: Effect of valdecoxib pretreatment on pain and secondary hyperalgesia associated with the heat/capsaicin model in healthy volunteers
Date of first enrolment: 01/01/2004
Target sample size: 40
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN05282752
Study type:  Interventional
Study design:  Prospective, double blind, randomized, cross-over (Treatment)  
Phase:  Not Applicable
Countries of recruitment
United States of America
Contacts
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Name: Piotr    Janicki
Address:  Penn State Hershey Medical Ctr Dept. Anesthesiology H187 500 University Drive PA 17036 Hershey United States of America
Telephone: -
Email: pjanicki@psu.edu
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Healthy volunteers, both genders
Exclusion criteria: Pregnancy, known allergy to COX-2 inhibitors, current infection or treatment with analgesics

Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Hyperalgesia
Signs and Symptoms
Intervention(s)
Administration of single dose 40 mg valdecoxib or placebo orally (PO).
Measurement of heat/cold pain threshold and area of heat/capsaicin-induced hyperalgesia.
Primary Outcome(s)
Area of secondary hyperalgesia
Secondary Outcome(s)
Pain threshold for cold/heat pain
Secondary ID(s)
NCT00260325
N/A
Source(s) of Monetary Support
Independent Investigator Grant from Pfizer Inc.
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history